View : 499 Download: 0
Iron tetrakis (N-methyl-4′-pyridyl) porphyrinato inhibits proliferative activity of thymocytes by blocking activation of p38 mitogen-activated protein kinase, nuclear factor-κB, and interleukin-2 secretion
- Title
- Iron tetrakis (N-methyl-4′-pyridyl) porphyrinato inhibits proliferative activity of thymocytes by blocking activation of p38 mitogen-activated protein kinase, nuclear factor-κB, and interleukin-2 secretion
- Authors
- Kang J.L.; Lee H.S.; Jung H.J.; Kim H.J.
- Ewha Authors
- 이지희
- SCOPUS Author ID
- 이지희
- Issue Date
- 2003
- Journal Title
- Toxicology and Applied Pharmacology
- ISSN
- 0041-008X
- Citation
- Toxicology and Applied Pharmacology vol. 191, no. 2, pp. 147 - 155
- Indexed
- SCI; SCIE; SCOPUS
- Document Type
- Article
- Abstract
- Iron tetrakis (N-methyl-4′-pyridyl) porphyrinato (FeTMPyP) has been demonstrated to be a potent scavenger of reactive oxygens and to have antiinflammatory activities. However, the effects of FeTMPyP on the function of T cells have not been illustrated. The objective of this study was to determine whether treatment of thymocytes with FeTMPyP inhibited the proliferative activity in response to various mitogens and, if so, to further characterize the mechanism of FeTMPyP immune modulation. The results indicate that treatment of thymocytes with FeTMPyP resulted in dose-dependent inhibition of thymocyte proliferation stimulated by concanawalin (Con) A-, Interleukin (IL)-1β; or lipopdy socchande-exposed macrophage supernatant. FeTMPyP treatment also inhibited Con A- or IL-1β-induced DNA-binding activity of NF-κB and IL-2 secretion by thymocytes. Both the p38 MAP kinase inhibitor SB203580 and the extracellular signal-regulated protein kinases inhibitor PD98059 blocked proliferative activity in Con A-stimulated thymocytes, while SB203580 but not PD98059 blocked nuclear factor (NF)-κB activation. FeTMPyP inhibited the activation and phosphorylation of p38 mitogen-activated protein kinase (MAPK) in response to Con A. These data suggest that FeTMPyP downregulates the proliferative activity by inhibition of p38 MAPK activation, NF-κB activation, and IL-2 secretion during mitogenic stimulation of thymocytes. Therefore, further studies concerning the effects of FeTMPyP on the human diseases associated with both inflammatory disorders and immunologic overactivation are warranted. © 2003 Elsevier Inc. All rights reserved.
- DOI
- 10.1016/S0041-008X(02)00044-3
- Appears in Collections:
- 의과대학 > 의학과 > Journal papers
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML